Current neurologic treatment and emerging therapies in CDKL5 deficiency disorder
Current neurologic treatment and emerging therapies in CDKL5 deficiency disorder
About this item
Full title
Author / Creator
Olson, Heather E. , Daniels, Carolyn I. , Haviland, Isabel , Swanson, Lindsay C. , Greene, Caitlin A. , Denny, Anne Marie M. , Demarest, Scott T. , Pestana-Knight, Elia , Zhang, Xiaoming , Moosa, Ahsan N. , Fidell, Andrea , Weisenberg, Judith L. , Suter, Bernhard , Fu, Cary , Neul, Jeffrey L. , Percy, Alan K. , Marsh, Eric D. , Benke, Timothy A. and Poduri, Annapurna
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
CDKL5 deficiency disorder (CDD) is associated with refractory infantile onset epilepsy, global developmental delay, and variable features that include sleep, behavioral disturbances, and movement disorders. Current treatment is primarily symptom-based and informed by experience in caring for this population.
We describe medication and non-medica...
Alternative Titles
Full title
Current neurologic treatment and emerging therapies in CDKL5 deficiency disorder
Authors, Artists and Contributors
Author / Creator
Daniels, Carolyn I.
Haviland, Isabel
Swanson, Lindsay C.
Greene, Caitlin A.
Denny, Anne Marie M.
Demarest, Scott T.
Pestana-Knight, Elia
Zhang, Xiaoming
Moosa, Ahsan N.
Fidell, Andrea
Weisenberg, Judith L.
Suter, Bernhard
Fu, Cary
Neul, Jeffrey L.
Percy, Alan K.
Marsh, Eric D.
Benke, Timothy A.
Poduri, Annapurna
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_b2a404d8a1fc4c57b3365dbe6a876c7d
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b2a404d8a1fc4c57b3365dbe6a876c7d
Other Identifiers
ISSN
1866-1947
E-ISSN
1866-1955
DOI
10.1186/s11689-021-09384-z
